Drug Discovery & Molecular Simulation
Classical supercomputers struggle with the exponential complexity of simulating molecular interactions at the quantum level. This leads to high attrition rates in the “hit-to-lead” phase of drug development.
The Solution: During discovery, we map your pipeline to Variational Quantum Eigensolvers (VQE). By simulating electron correlations and protein folding with quantum kernels, we can identify viable drug candidates with a 40% reduction in lead-time.